2-(Difluoromethoxy)-4-fluoro-5-nitroaniline, 95%, 1g

iScope IS.1153-PLi/DFi Triocular with Plan IOS objectives and Rackless cross stage (dark field contrast application)

3-((Benzyloxy)methyl)cyclobutanone, 95.0%, 5g

Ethyl 2-bromoimidazo[2,1-b][1,3,4]thiadiazole-6-carboxylate, 97%, 1g

3-Amino-3-(2-bromophenyl)propanoic acid, 95.0%, 1g

1,3-Benzodithiolylium Tetrafluoroborate [Hydroxyl-Protecting Agent]>96.0%(T)5g

4-Bromo-1,2-bis(trifluoromethyl)benzene, 95.0%, 250mg

4-CHLORO-N-PHENYLPICOLINAMIDE, 95.0%, 250mg

Methyl 5-bromoquinoline-8-carboxylate, 95.0%, 250mg

4-(6-Oxo-1,6-dihydropyridazin-3-yl)benzoic acid, 95%, 100mg

5-Bromo-2-chloro-N4-ethylpyridine-3,4-diamine, 98%, 1g

8-bromo-N,N-dimethyl-1,6-naphthyridin-5-amine, 95.0%, 1g

8-BROMO-2-METHYLQUINOLIN-4-AMINE, 95%, 250mg